Clear Street’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273 Buy
6,228
+200
+3% +$19 ﹤0.01% 1067
2025
Q4
$726 Sell
6,028
-100
-2% -$16 ﹤0.01% 878
2025
Q3
$735 Hold
6,128
﹤0.01% 782
2025
Q2
$314 Sell
6,128
-500
-8% -$32 ﹤0.01% 631
2025
Q1
$180 Buy
6,628
+5,000
+307% +$130 ﹤0.01% 530
2024
Q4
$8 Sell
1,628
-265
-14% -$4 ﹤0.01% 575
2024
Q3
$38 Sell
1,893
-500
-21% -$10 ﹤0.01% 675
2024
Q2
$63 Buy
2,393
+800
+50% +$62 ﹤0.01% 748
2024
Q1
$319 Hold
1,593
﹤0.01% 702
2023
Q4
$319 Buy
1,593
+500
+46% +$79 ﹤0.01% 717
2023
Q3
$100 Buy
1,093
+700
+178% +$57 ﹤0.01% 1027
2023
Q2
$11 Buy
393
+200
+104% +$11 ﹤0.01% 1278
2023
Q1
$13 Buy
+193
New +$24 ﹤0.01% 1155

Other funds holding TOIIW

Clear Street's TOIIW Position: Q1 2026 in Review

Clear Street increased its The Oncology Institute Warrant (TOIIW) stake by 3.3% in Q1 2026, buying an estimated $19 and bringing the position to 6,228 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Clear Street first reported a position in TOIIW in Q1 2023 and has held it in 13 quarters since. The position peaked at $735 in Q3 2025. 11 funds tracked by Wall St. Rank hold TOIIW as of Q1 2026.

  • Clear Street held 6,228 shares of The Oncology Institute Warrant worth $273 as of Q1 2026.
  • Clear Street bought 200 The Oncology Institute Warrant shares in Q1 2026, an estimated $19.
  • The Oncology Institute Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1067 holding.
  • Clear Street first reported a position in The Oncology Institute Warrant in Q1 2023 and has held it in 13 quarters since.
  • Clear Street's The Oncology Institute Warrant position peaked at $735 in Q3 2025.
  • 11 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.